|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1969-7-3
|
|
pubmed:keyword |
http://linkedlifedata.com/resource/pubmed/keyword/Biology,
http://linkedlifedata.com/resource/pubmed/keyword/Carbohydrate Metabolic Effects,
http://linkedlifedata.com/resource/pubmed/keyword/Chlormadinone Acetate,
http://linkedlifedata.com/resource/pubmed/keyword/Clinical Research,
http://linkedlifedata.com/resource/pubmed/keyword/Contraception,
http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Agents, Estrogen,
http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Agents, Progestin,
http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Methods--side effects,
http://linkedlifedata.com/resource/pubmed/keyword/Correlation Studies,
http://linkedlifedata.com/resource/pubmed/keyword/Examinations And Diagnoses,
http://linkedlifedata.com/resource/pubmed/keyword/Family Planning,
http://linkedlifedata.com/resource/pubmed/keyword/GLUCOSE TOLERANCE TEST,
http://linkedlifedata.com/resource/pubmed/keyword/Glucose Metabolism Effects,
http://linkedlifedata.com/resource/pubmed/keyword/Human Volunteers,
http://linkedlifedata.com/resource/pubmed/keyword/Laboratory Examinations And Diagnoses,
http://linkedlifedata.com/resource/pubmed/keyword/Laboratory Procedures,
http://linkedlifedata.com/resource/pubmed/keyword/Mestranol,
http://linkedlifedata.com/resource/pubmed/keyword/Metabolic Effects,
http://linkedlifedata.com/resource/pubmed/keyword/Minnesota,
http://linkedlifedata.com/resource/pubmed/keyword/Oral Contraceptives, Combined,
http://linkedlifedata.com/resource/pubmed/keyword/Oral Contraceptives, Phasic,
http://linkedlifedata.com/resource/pubmed/keyword/Oral Contraceptives--side effects,
http://linkedlifedata.com/resource/pubmed/keyword/Physiology,
http://linkedlifedata.com/resource/pubmed/keyword/Research Methodology,
http://linkedlifedata.com/resource/pubmed/keyword/Statistical Studies,
http://linkedlifedata.com/resource/pubmed/keyword/Studies,
http://linkedlifedata.com/resource/pubmed/keyword/United States,
http://linkedlifedata.com/resource/pubmed/keyword/VAGINITIS
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0029-7844
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
33
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
800-4
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:otherAbstract |
PIP: Plasma insulin and blood glucose were measured during an intravenous glucose tolerance test at the University of Minnesota hospital clinic on 28 women on oral sequential contraceptives (15 tablets of 80 mu-g mestranol, 5 tablets of 80 MCG mestranol and 2 mg chlormadinone acetate) both prior to drug initiation and after 1 year of use. No statistical difference in either glucose or insulin levels or weight change was seen after 1 year of therapy. A significant positive association was found between the elevation of glucose and insulin with the drug at cerain time periods during the glucose test, and if there was a family history of diabetes mellitus. A higher frequency of abnormal glucose and insulin levels has been found among users of combination-type drugs as compared to the sequential type.
|
|
pubmed:meshHeading |
pubmed-meshheading:4181554-Blood Glucose,
pubmed-meshheading:4181554-Body Weight,
pubmed-meshheading:4181554-Carbohydrate Metabolism,
pubmed-meshheading:4181554-Chlormadinone Acetate,
pubmed-meshheading:4181554-Contraceptives, Oral,
pubmed-meshheading:4181554-Female,
pubmed-meshheading:4181554-Humans,
pubmed-meshheading:4181554-Insulin,
pubmed-meshheading:4181554-Mestranol,
pubmed-meshheading:4181554-Pregnancy,
pubmed-meshheading:4181554-Radioimmunoassay
|
|
pubmed:year |
1969
|
|
pubmed:articleTitle |
Insulin and glucose studies after one year of treatment with a sequential-type oral contraceptive.
|
|
pubmed:publicationType |
Journal Article
|
